Nearly three years after the Drug Enforcement Agency announced it would end a monopoly on who can grow cannabis for legally sanctioned research, there’s still only one federally authorized cannabis cultivator in the United States.

The limited supply of research cannabis is hampering the speed, quality and range of studies that scientists can conduct on the potential medical benefits of marijuana.

See the original article at The OCR